Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Careful monitoring may be warranted to distinguish disease flares from medication-related effects
Dihexa has not been studied for safety and efficacy in large-scale human clinical trials, some risks may be hypothesized from its mechanism of action
If you experience side effects, its okay to stay at your current dose
A timeline of events
Tirzepatide (Zepbound, Mounjaro) Zepbound is approved to treat obesity in adults with a BMI of 30 or greater or overweight with weight-related health conditions
In a clinical trial in patients with type 1 diabetes, NOVOLOG and regular human insulin, both administered subcutaneously at a dose of 0.15 units/kg body weight, reached mean maximum concentrations of 82 and 36 mU/L, respectively
US$ 25.41
US$ 23.49
US$ 24.66
US$ 25.98
